← Open Payments lookup

DINALBEN PATEL: Open Payments

NPI 1851858971 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,345 in 56 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,345

Food & beverage: $1,345
CompanyPaymentsAmount
ABBVIE INC.21$418
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$174
Ardelyx, Inc.6$110
Janssen Biotech, Inc.3$93
Takeda Pharmaceuticals U.S.A., Inc.3$92
GENZYME CORPORATION4$90
Regeneron Healthcare Solutions, Inc.3$89
Madrigal Pharmaceuticals3$74
QOL Medical, LLC3$71
Aimmune Therapeutics, Inc.3$63

Products named: SKYRIZI, XIFAXAN, RINVOQ, DUPIXENT, IBSRELA, TREMFYA, REZDIFFRA, Sucraid.

Industry payments across TX — which companies pay providers there.